1645 related articles for article (PubMed ID: 27231109)
21. [The new generation tool for CRISPR genome editing: CRISPR/Cpf1].
Yang F; Li Y
Sheng Wu Gong Cheng Xue Bao; 2017 Mar; 33(3):361-371. PubMed ID: 28941336
[TBL] [Abstract][Full Text] [Related]
22. Battling CRISPR-Cas9 off-target genome editing.
Li D; Zhou H; Zeng X
Cell Biol Toxicol; 2019 Oct; 35(5):403-406. PubMed ID: 31313008
[No Abstract] [Full Text] [Related]
23. Cutting Edge Genetics: CRISPR/Cas9 Editing of Plant Genomes.
Soyars CL; Peterson BA; Burr CA; Nimchuk ZL
Plant Cell Physiol; 2018 Aug; 59(8):1608-1620. PubMed ID: 29912402
[TBL] [Abstract][Full Text] [Related]
24. Genetic screens and functional genomics using CRISPR/Cas9 technology.
Hartenian E; Doench JG
FEBS J; 2015 Apr; 282(8):1383-93. PubMed ID: 25728500
[TBL] [Abstract][Full Text] [Related]
25. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas based gene editing: marking a new era in medical science.
Prasad K; George A; Ravi NS; Mohankumar KM
Mol Biol Rep; 2021 May; 48(5):4879-4895. PubMed ID: 34143395
[TBL] [Abstract][Full Text] [Related]
27. Minimizing off-target effects in CRISPR-Cas9 genome editing.
Chen SJ
Cell Biol Toxicol; 2019 Oct; 35(5):399-401. PubMed ID: 31317359
[No Abstract] [Full Text] [Related]
28. Genome engineering using CRISPR-Cas9 system.
Cong L; Zhang F
Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
30. Selection and Validation of Spacer Sequences for CRISPR-Cas9 Genome Editing and Transcription Regulation in Bacteria.
Grenier F; Lucier JF; Rodrigue S
Methods Mol Biol; 2015; 1334():233-44. PubMed ID: 26404154
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in CRISPR/Cas9 mediated genome editing in Bacillus subtilis.
Hong KQ; Liu DY; Chen T; Wang ZW
World J Microbiol Biotechnol; 2018 Sep; 34(10):153. PubMed ID: 30269229
[TBL] [Abstract][Full Text] [Related]
32. Development and application of CRISPR/Cas9 technologies in genomic editing.
Zhang C; Quan R; Wang J
Hum Mol Genet; 2018 Aug; 27(R2):R79-R88. PubMed ID: 29659822
[TBL] [Abstract][Full Text] [Related]
33. Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies.
Amritha PP; Shah JM
Mol Genet Genomics; 2021 May; 296(3):485-500. PubMed ID: 33751237
[TBL] [Abstract][Full Text] [Related]
34. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
35. CRISPR/Cas9-based genome engineering of zebrafish using a seamless integration strategy.
Luo JJ; Bian WP; Liu Y; Huang HY; Yin Q; Yang XJ; Pei DS
FASEB J; 2018 Sep; 32(9):5132-5142. PubMed ID: 29812974
[TBL] [Abstract][Full Text] [Related]
36. Genome editing: The domestication of Cas9.
Urnov F
Nature; 2016 Jan; 529(7587):468-9. PubMed ID: 26819037
[No Abstract] [Full Text] [Related]
37. CRISPR/Cas9: an advanced tool for editing plant genomes.
Samanta MK; Dey A; Gayen S
Transgenic Res; 2016 Oct; 25(5):561-73. PubMed ID: 27012546
[TBL] [Abstract][Full Text] [Related]
38. Genome engineering in ophthalmology: Application of CRISPR/Cas to the treatment of eye disease.
Hung SSC; McCaughey T; Swann O; Pébay A; Hewitt AW
Prog Retin Eye Res; 2016 Jul; 53():1-20. PubMed ID: 27181583
[TBL] [Abstract][Full Text] [Related]
39. Genome Editing and Its Applications in Model Organisms.
Ma D; Liu F
Genomics Proteomics Bioinformatics; 2015 Dec; 13(6):336-44. PubMed ID: 26762955
[TBL] [Abstract][Full Text] [Related]
40. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups.
Song M
Biotechnol Prog; 2017 Jul; 33(4):1035-1045. PubMed ID: 28440027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
